Riskpilot← Back to searchSign inGet full accessPAUSE1 AS
ASActiveOrg 922134553Valkendorfsgaten 5, 5012 BergenMedical specialists activities · NACE 8622Est. 20191 employees
Revenue 2025
NOK 7,2M
+12% vs 2024
EBITDA margin
26.5%
+48% vs 2024
Equity ratio
68.0%
Financial strength
Net profit 2025
NOK 1,3M
+51% vs 2024
| Revenue | NOK 7,2M | +12% |
| EBITDA | NOK 1,9M | +48% |
| Net profit | NOK 1,3M | +51% |
| Total assets | NOK 5,8M | +61% |
| Equity | NOK 4M | +49% |
| Employees | 1 | — |
Legal name
PAUSE1 AS
Org number
922134553
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
30. januar 2019
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Spesialistpraksis, med det som naturlig faller inn under dette, samt investering i eiendom, selskaper og prosjekter av enhver art, og annet som naturlig faller inn under dette, herunder delta i andre selskaper med lignende virksomhet.
Address
Valkendorfsgaten 5, 5012 Bergen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 170 | 4 899 | 5 156 | 6 415 | 7 206 |
| Staff expenses | −1 831 | −1 927 | −1 980 | −1 980 | −1 979 |
| EBITDA | 467 | 439 | 521 | 1 287 | 1 908 |
| Depreciation & amort. | −0 | −0 | −0 | −200 | −246 |
| EBIT | 467 | 439 | 521 | 1 087 | 1 661 |
| Net financials | 0 | 0 | 5 | 24 | 12 |
| Profit before tax | 467 | 440 | 525 | 1 112 | 1 674 |
| Tax | 103 | 97 | 114 | 245 | 369 |
| Net profit | 364 | 343 | 411 | 867 | 1 305 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 799 | 2 143 | 2 460 | 3 603 | 5 816 |
| Equity | 1 030 | 1 373 | 1 784 | 2 651 | 3 956 |
| Long-term debt | 0 | 0 | 0 | 0 | 1 103 |
| Short-term debt | 768 | 770 | 676 | 951 | 757 |
| Total debt | 768 | 770 | 676 | 951 | 1 860 |
EBITDA margin
26.5%
This company
15.8%
Market median
+68% vs market
20212025
Equity ratio
68.0%
This company
38.2%
Market median
+78% vs market
20212025
Return on equity
33.0%
This company
18.4%
Market median
+79% vs market
20212025
Net profit margin
18.1%
This company
8.1%
Market median
+123% vs market
20212025
Asset turnover
1.24×
This company
1.12×
Market median
+11% vs market
20212025
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PT Chief Executive Officer | Chief Executive Officer | 2019 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PAUSE1 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pål Tørvik-Pedersen | Chief Executive Officer | 0 companies |